Site search
2831 results for '' found
Colchicine After Stroke to Prevent Event Recurrence (CASPER) A randomised trial to evaluate the efficacy of oral Colchicine in high-risk patients with atherosclerosis-associated inflammation post
Colchicine After Stroke to Prevent Event Recurrence (CASPER) A randomised trial to evaluate the efficacy of oral Colchicine in high-risk patients with atherosclerosis-associated inflammation post
/
A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BC
A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BC
/
A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexameth
A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexameth
/
Concentrated Albumin infusion Prior to Rescue Infliximab (CAPRI) in steroid refractory Acute Severe Ulcerative Colitis (ASUC), a randomized clinical trial (ACTRN12619001081101p)
Concentrated Albumin infusion Prior to Rescue Infliximab (CAPRI) in steroid refractory Acute Severe Ulcerative Colitis (ASUC), a randomized clinical trial (ACTRN12619001081101p)
/
CAPLA trial: Catheter Ablation for persistent atrial fibrillation: A Multicentre randomised trial of Pulmonary vein isolation (PVI) vs PVI with posterior Left Atrial wall isolation (PWI) (ACTRN12
CAPLA trial: Catheter Ablation for persistent atrial fibrillation: A Multicentre randomised trial of Pulmonary vein isolation (PVI) vs PVI with posterior Left Atrial wall isolation (PWI) (ACTRN12
/
Catheter Ablation versus Medical Rate Control of Atrial Fibrillation in Patients with Systolic Heart Failure and Myocardial Fibrosis - An MRI Guided Multi-Centre Randomised Controlled Trial (CAME
Catheter Ablation versus Medical Rate Control of Atrial Fibrillation in Patients with Systolic Heart Failure and Myocardial Fibrosis - An MRI Guided Multi-Centre Randomised Controlled Trial (CAME
/
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant [AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader] Versus Standard Endocr
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant [AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader] Versus Standard Endocr
/
A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive d
A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive d
/
Multicentre, adaptive, double blind, three arm placebo-controlled, non-inferiority trial examining antimicrobial prophylaxis duration in cardiac surgery (NCT05447559)
Multicentre, adaptive, double blind, three arm placebo-controlled, non-inferiority trial examining antimicrobial prophylaxis duration in cardiac surgery (NCT05447559)
/